Effects of Oncogenic Gαq and Gα11 Inhibition by FR900359 in Uveal Melanoma.
Ontology highlight
ABSTRACT: Uveal melanoma is the most common intraocular tumor in adults and often metastasizes to the liver, leaving patients with few options. Recurrent activating mutations in the G proteins, Gαq and Gα11, are observed in approximately 93% of all uveal melanomas. Although therapeutic intervention of downstream Gαq/11 targets has been unsuccessful in treating uveal melanoma, we have found that the Gαq/11 inhibitor, FR900359 (FR), effectively inhibits oncogenic Gαq/11 signaling in uveal melanoma cells expressing either mutant Gαq or Gα11. Inhibition of oncogenic Gαq/11 by FR results in cell-cycle arrest and induction of apoptosis. Furthermore, colony formation is prevented by FR treatment of uveal melanoma cells
SUBMITTER: Lapadula D
PROVIDER: S-EPMC6445713 | biostudies-literature | 2019 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA